Jennifer Rea, MD
Colon & Rectal Surgery · Lexington, KYNPI 1386853190
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 79.3% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2019 at $23,583 and has fallen 97.9% since, to $484 in 2025. Among colon & rectal surgery clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $78.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$23K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$404
- Johnson & Johnson$352
- Davol Inc.$306
- plus $2K from 32 others
What the payments were for
- Travel & lodging$5,08418%
- Food & beverage$6,77523%
- Education$17,02759%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 33 | $22,909 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 94 | $1,505 |
| AbbVie | 90 | $1,386 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $404 |
| Johnson & Johnson(2 entities) | 23 | $352 |
| Davol Inc. | 4 | $306 |
| Ferring Pharmaceuticals Inc. | 13 | $183 |
| Medtronic(2 entities) | 3 | $183 |
| QOL Medical, LLC | 9 | $167 |
| Bristol Myers Squibb | 10 | $152 |
| Janssen Scientific Affairs, LLC | 1 | $144 |
| Palette Life Sciences, Inc. | 1 | $125 |
| Lilly USA, LLC | 6 | $125 |
| Romark Laboratories, LC | 4 | $90 |
| Axonics, Inc. | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| KARL Storz Endoscopy-america | 1 | $70 |
| Nestle Healthcare Nutrition Inc. | 4 | $62 |
| Amgen | 4 | $61 |
| UCB, Inc. | 4 | $49 |
| Merck | 3 | $47 |
| Covidien LP | 1 | $41 |
| Sanofi | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Integra Lifesciences Corporation | 1 | $34 |
| Pfizer | 2 | $34 |
| TELA Bio, Inc. | 2 | $31 |
| Eagle Pharmaceuticals, Inc. | 1 | $28 |
| Evoke Pharma, Inc. | 2 | $28 |
| La Jolla Pharmaceutical Company | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Shionogi Inc | 1 | $17 |
| Celltrion USA Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Ardelyx, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Convatec Inc. | 1 | $13 |
| Heron Therapeutics, Inc. | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$22,538
- BD MAX$129
- Solesta$125
How this compares
$28,885 in reported general payments places this provider in the 95th percentile of 28 colon & rectal surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DipentumOlsalazine Sodium | 11 | $18,889 |
| TrulancePlecanatide | 19 | $17,808 |
| LinzessLinaclotide | 22 | $15,108 |
| MotegrityPrucalopride Succinate | 12 | $9,525 |
| Mesalamine | 16 | $6,886 |
| Mesalamine ErMesalamine | 21 | $3,154 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 11 | $1,836 |
| Lubiprostone | 11 | $1,746 |
| Colestipol Hcl | 21 | $1,344 |
| LoperamideLoperamide Hcl | 34 | $579 |
| Sulfasalazine DrSulfasalazine | 11 | $344 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 26 | $282 |
| Neomycin Sulfate | 43 | $229 |
| Ondansetron Hcl | 21 | $165 |
| Metronidazole | 49 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $1,505 | $17,80819 claims |
| AbbVieLinzess | $1,386 | $15,10822 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $404 | $9,52512 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $183 | $1,83611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 28 colon & rectal surgery providers in Kentucky.
Other colon & rectal surgery in Lexington
- Alfred CohenLexington$76K
- Bruce BelinLexington$19K
- John DvorakLexington$13K
- Jitesh PatelLexington$12K
- Charles PappLexington$9K
- David SvetichLexington$8K
- Frank RutiglianoLexington$7K
- Sandra BeckLexington$6K
- Jon HouriganLexington$4K
- Avinash BhaktaLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.